Effect of a Novel Steroid (PM-9) on the Inhibition of 5α-Reductase in Penicillium Crustosum Broths
March 2003
in “
Steroids
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that both finasteride and a new steroidal compound, PM-9, competitively inhibit the 5α-reductase enzyme in Penicillium crustosum broth.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the inhibition of the 5α-reductase enzyme in Penicillium crustosum broth by finasteride and a novel steroidal compound, PM-9. The enzyme, which converts testosterone to dihydrotestosterone (DHT), was inhibited in a competitive manner by both compounds. This research aimed to explore alternatives to animal testing for evaluating 5α-reductase inhibitors, which are relevant for treating conditions like benign prostatic hyperplasia and prostate cancer. The findings demonstrated that both finasteride and PM-9 effectively inhibited the enzyme in the broth, similar to their effects in animal models.
